It’s been quite the week for Herbalife, the controversial nutrition and supplement company that’s had the hedge fund world divided for more than a year. A series of regulatory inquiries and personnel changes have sent the stock on a roller coaster ride that started Thursday with a nosedive after Massachusetts senator Ed Markey called for Federal Trade Commission and Securities and Exchange Commission inquiries into a possible pyramid scheme at the southern California-based company.
It’s been uphill and back downhill from there. On Monday, after opening at around $60 per share, Herbalife shares rallied all the way back up to nearly $66 each on the heels of an announcement that a top analyst of the company was leaving his role at D.A. Davidson to join Post Holdings, a major shareholder of Herbalife.
But the high wouldn’t last long. On Tuesday, a top regulator in the Canadian government announced its own inquiry into Herbalife, likely to the delight of Bill Ackman, who has been shorting the stock for more than a year, only to have the company push back on him with its own campaign to persuade investors in his Pershing Square Capital hedge fund to pull their money.
The Canadian Competition Bureau’s investigation sent Herbalife’s stock in a downward spiral yet again, and it even neared the $60 mark for the second time in two days.
Who knows what tomorrow will bring?
- We've compiled an extensive (but not exhaustive) list of lies, exaggerations, and bullshit from Trump's first 100 days in office 💯
- An admitted fraudster has access to Trump through his wife's job at Mar-a-Lago — and he's tried to use it to his advantage.
- Arkansas executed Kenneth Williams Thursday night — just days before one of the state's execution drugs expires.
- Beginning in 2018, prescription drugs will be free for anyone under the age of 25 in Ontario, Canada, government says.